HOTH THERAPEUTICS INC (HOTH) Stock Income Statement
USA - NASDAQ:HOTH - US44148G2049 - Common Stock
1.18 USD
-0.1 (-7.81%)
1.19 USD
+0.01 (+0.85%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 10.19M | 8.22M | 7.69M | 11.07M | 14.10M | |||
| Research and Development | 5.22M | 3.25M | 3.48M | 4.93M | 7.53M | |||
| Selling, General, and Administrative Expenses | 4.97M | 4.97M | 4.21M | 5.15M | 5.79M | |||
| Operating Income | -10.19M | -8.22M | -7.69M | -11.07M | -14.10M | |||
| Interest Income/Expense | 800 | 27.10K | -153.20K | -760.00K | null | |||
| Other Income/Expense | null | null | 0 | 450.00K | -210.00K | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -10.19M | -8.19M | -7.85M | -11.37M | -14.31M | |||
| Income Tax | null | null | null | null | null | |||
| Net Income | -10.19M | -8.19M | -7.85M | -11.37M | -14.31M | |||
| EBITDA | null | undefined | undefined | undefined | undefined | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.0759 | -1.2844 | -2.3013 | -9.47 | -16.07 | |||
| Non GAAP EPS | -1.07 | -1.33 | -2.3699999999999997 | -9.91 | -16.5 | |||
| Statistics | ||||||||
All data in USD